DexCom shares are trading higher after RBC Capital initiated coverage on the stock with an Outperform rating and $165 price target.
Portfolio Pulse from Benzinga Newsdesk
DexCom's stock (DXCM) is trading higher following an Outperform rating and a $165 price target initiation by RBC Capital.
March 13, 2024 | 1:21 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
DexCom's stock received an Outperform rating and a $165 price target from RBC Capital, indicating a positive outlook.
The Outperform rating and $165 price target set by RBC Capital for DexCom (DXCM) suggest a strong positive sentiment towards the stock. This analyst endorsement can significantly influence investor perception and potentially drive the stock price higher in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100